1. Netland PA. The Ahmed glaucoma valve in neovascular glaucoma (An AOS Thesis). Trans Am Ophthalmol Soc. 2009; 107:325–42.
2. Hayreh SS. Neovascular glaucoma. Prog Retin Eye Res. 2007; 26:470–85.
Article
3. Liang CM. Chen YH. Lu DW, et al. New continuous air pumping technique to improve clinical outcomes of descemet-stripping automated endothelial keratoplasty in Asian patients with previous ahmed glaucoma valve implantation. PloS One. 2013; 8:e72089.
Article
4. Netland PA. Ishida K. Boyle JW. The Ahmed glaucoma valve in patients with and without neovascular glaucoma. J Glaucoma. 2010; 19:581–6.
Article
5. Lloyd MA. Heuer DK. Baerveldt G, et al. Combined molteno implantation and pars plana vitrectomy for neovascular glaucomas. Ophthalmology. 1991; 98:1401–5.
Article
6. Moon DRC. Choi KS. Lee SJ. Ha SJ. Vitrectomy and Ahmed valve implantation in neovascular glaucoma patients with vitreous hemorrhage. J Korean Ophthalmol Soc. 2012; 53:801–6.
Article
7. Scott IU. Alexandrakis G. Flynn HW Jr, et al. Combined pars plana vitrectomy and glaucoma drainage implant placement for refractory glaucoma. Am J Ophthalmol. 2000; 129:334–41.
Article
8. Lee CM. Kim EA. Cho YW. Pars plana vitrectomy and Ahmed valve implantation for intractable glaucoma comorbid with retinal disorders. J Korean Ophthalmol Soc. 2011; 52:46–52.
Article
9. Lee JJ. Park KH. Kim DM. Kim TW. Clinical outcomes of Ahmed glaucoma valve implantation using tube ligation and removable external stents. Korean J Ophthalmol. 2009; 23:86–92.
Article
10. Shazly TA. Latina MA. Neovascular glaucoma: etiology, diagnosis and prognosis. Semin Ophthalmol. 2009; 24:113–21.
Article
11. Coleman AL. Hill R. Wilson MR, et al. Initial clinical experience with the Ahmed Glaucoma Valve implant. Am J Ophthalmol. 1995; 120:23–31.
Article
12. Susanna R Jr. Latin American Glaucoma Society Investigators. Partial Tenon’s capsule resection with adjunctive mitomycin C in Ahmed glaucoma valve implant surgery. Br J Ophthalmol. 2003; 87:994–8.
13. Sone H. Okuda Y. Kawakami Y, et al. Vascular endothelial growth factor level in aqueous humor of diabetic patients with rubeotic glaucoma is markedly elevated. Diabetes Care. 1996; 19:1306–7.
Article
14. Stefánsson E. Physiology of vitreous surgery. Graefes Arch Clin Exp Ophthalmol. 2009; 247:147–63.
Article
15. Barile GR. Chang S. Horowitz JD, et al. Neovascular complications associated with rubeosis iridis and peripheral retinal detachment after retinal detachment surgery. Am J Ophthalmol. 1998; 126:379–89.
Article
16. Sivak-Callcott JA. O’Day DM. Gass JD. Tsai JC. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology. 2001; 108:1767–76. quiz1777, 1800.
17. Fekrat S. Finkelstein D. Current concepts in the management of central retinal vein occlusion. Curr Opin Ophthalmol. 1997; 8:50–4.
Article
18. Kang JY. Nam KY. Lee SJ. Lee SU. The effect of intravitreal bevacizumab injection before Ahmed valve implantation in patients with neovascular glaucoma. Int Ophthalmol. 2014; 34:793–9.
Article
19. Ma KT. Yang JY. Kim JH, et al. Surgical results of Ahmed valve implantation with intraoperative bevacizumab injection in patients with neovascular glaucoma. J Glaucoma. 2012; 21:331–6.
Article
20. Hwang HB. Han JW. Yim HB. Lee NY. Beneficial effects of adjuvant intravitreal bevacizumab injection on outcomes of Ahmed glaucoma valve implantation in patients with neovascular glaucoma: systematic literature review. J Ocul Pharmacol Ther. 2015; 31:198–203.
Article